Fundz

Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer

PUBLIC · BEAMDec 06, 2024

Position

Chief Financial Officer

Company

Beam Therapeutics Inc.

Sravan K. Emany
CambridgeBiotechnologyHealthcareHealth CareTherapeutics

Description

Beam Therapeutics Inc. announced the appointment of Sravan K. Emany as chief financial officer (CFO), effective December 19, 2024

Quick answer

Beam Therapeutics Inc. Appoints Sravan K. Emany as Chief Financial Officer (December 6, 2024). Beam Therapeutics Inc. is based in Cambridge, Massachusetts, United States.

Who is the new Chief Financial Officer at Beam Therapeutics Inc?
Beam Therapeutics Inc. named Sravan K. Emany Chief Financial Officer, announced December 6, 2024.
What did Beam Therapeutics Inc. announce on December 6, 2024?
Beam Therapeutics Inc. announced the appointment of Sravan K. Emany as chief financial officer (CFO), effective December 19, 2024
What does Beam Therapeutics Inc. do?
Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines.
Where is Beam Therapeutics Inc. based?
Beam Therapeutics Inc. is based in Cambridge, Massachusetts, United States.
Which similar companies made leadership changes around the same time?
Azora Therapeutics, Inc. (DE) (November 5, 2024), Amylyx Pharmaceuticals (January 6, 2025), Verastem Oncology (January 15, 2025) and CERo Therapeutics Holdings (December 6, 2024) also announced leadership changes within 45 days of Beam Therapeutics Inc.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Therapeutics

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Beam Therapeutics Inc., and when

A new leader at Beam Therapeutics Inc. brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Beam Therapeutics Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Beam Therapeutics Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Beam Therapeutics Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Beam Therapeutics Inc.

Location

325 VASSAR STREET, SUITE 2A

Cambridge, Massachusetts, United States

About

Beam Therapeutics, launched in 2018, is pioneering the use of CRISPR base editing to develop a broad portfolio of advanced genetic medicines. Our groundbreaking base editing technology allows us to make permanent, specific edits to single bases in DNA and RNA, without cutting the strands. Base editor therapeutics represent a new class of “precision genetic medicines,” combining precision targeting of the genome with precision control of editing outcomes.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Beam Therapeutics Inc. changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Beam Therapeutics Inc.'s next move

Learn about Strategic plan

Beam Therapeutics Inc. changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.